A survey of combination antidepressant use in Australia
Data(s) |
01/01/2007
|
---|---|
Resumo |
<b>Objective: </b>The aim of this study was to survey doctors working in psychiatry in Australia about the practice of using two antidepressants simultaneously.<br /><br /><b>Method: </b>A postal survey was sent to all doctors in psychiatry in Australia enquiring about their prescribing history and their attitudes to combination antidepressants and related issues.<br /><br /><b>Results: </b>Seventy-nine percent of respondents had used combination antidepressants. The most frequently reported combination was a selective serotonin reuptake inhibitor combined with a tricyclic antidepressant. Combinations of mirtazepine with venlafaxine and other antidepressants were the next most frequently used. Seventeen percent of respondents reported having seen a complication from combination antidepressants, 75% believed that Australian GPs should be given information on the use of combination antidepressants, 89% wished for more information on this topic, and 88% believed patients had a right to be informed of this option in their treatment. Use of combination antidepressants was more frequent than exceeding the recommended maximum dose of an individual antidepressant.<br /><b><br />Conclusion:</b> Combination antidepressants are used far more frequently in Australia than suspected previously. Research into safe and evidence-based practice is strongly indicated.<br /> |
Identificador | |
Idioma(s) |
eng |
Publicador |
Informa Healthcare |
Relação |
http://dro.deakin.edu.au/eserv/DU:30035631/dodd-surveyofcombination-2007.pdf http://dx.doi.org/10.1080/10398560601109855 |
Direitos |
2007, The Royal Australian and New Zealand College of Psychiatrists |
Palavras-Chave | #Australia #combination antidepressants #survey #treatment |
Tipo |
Journal Article |